SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical-pathologic correlations.
SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical-pathologic correlations.
复制标题
DOI:
10.1016/j.ajog.2022.10.001
复制
发表时间:
2023-03
影响因子:
9.8
通讯作者:
中科院分区:
文献类型:
--
作者:
Stillbirth is a recognized complication of COVID-19 in pregnant women that has recently been demonstrated to be caused by SARS-CoV-2 infection of the placenta. Multiple global studies have found that the placental pathology present in cases of stillbirth consists of a combination of concurrent destructive findings that include increased fibrin deposition that typically reaches the level of massive perivillous fibrin deposition, chronic histiocytic intervillositis, and trophoblast necrosis. These 3 pathologic lesions, collectively termed SARS-CoV-2 placentitis, can cause severe and diffuse placental parenchymal destruction that can affect >75% of the placenta, effectively rendering it incapable of performing its function of oxygenating the fetus and leading to stillbirth and neonatal death via malperfusion and placental insufficiency. Placental infection and destruction can occur in the absence of demonstrable fetal infection. Development of SARS-CoV-2 placentitis is a complex process that may have both an infectious and immunologic basis. An important observation is that in all reported cases of SARS-CoV-2 placentitis causing stillbirth and neonatal death, the mothers were unvaccinated. SARS-CoV-2 placentitis is likely the result of an episode of SARS-CoV-2 viremia at some time during the pregnancy. This article discusses clinical and pathologic aspects of the relationship between maternal COVID-19 vaccination, SARS-CoV-2 placentitis, and perinatal death.
登录
查看更多内容
影响因子:
9.8
作者:
Gurol-Urganci I;Jardine JE;Carroll F;Draycott T;Dunn G;Fremeaux A;Harris T;Hawdon J;Morris E;Muller P;Waite L;Webster K;van der Meulen J;Khalil A
通讯作者:
Khalil A
DOI:
10.1016/j.diagmicrobio.2021.115595
发表时间:
2022-03
影响因子:
2.9
作者:
Hagman K;Hedenstierna M;Rudling J;Gille-Johnson P;Hammas B;Grabbe M;Jakobsson J;Dillner J;Ursing J
通讯作者:
Ursing J
影响因子:
7.3
作者:
Goldstein JA;Gallagher K;Beck C;Kumar R;Gernand AD
通讯作者:
Gernand AD
DOI:
10.15585/mmwr.mm7107e3
发表时间:
2022-02-18
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Halasa NB;Olson SM;Staat MA;Newhams MM;Price AM;Boom JA;Sahni LC;Cameron MA;Pannaraj PS;Bline KE;Bhumbra SS;Bradford TT;Chiotos K;Coates BM;Cullimore ML;Cvijanovich NZ;Flori HR;Gertz SJ;Heidemann SM;Hobbs CV;Hume JR;Irby K;Kamidani S;Kong M;Levy ER;Mack EH;Maddux AB;Michelson KN;Nofziger RA;Schuster JE;Schwartz SP;Smallcomb L;Tarquinio KM;Walker TC;Zinter MS;Gilboa SM;Polen KN;Campbell AP;Randolph AG;Patel MM;Overcoming COVID-19 Investigators;Overcoming COVID-19 Network
通讯作者:
Overcoming COVID-19 Network
影响因子:
9.8
作者:
Benachi, Alexandra;Rabant, Marion;Zuber, Julien
通讯作者:
Zuber, Julien